These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy. Eltonsy S; Forget A; Beauchesne MF; Blais L J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849 [TBL] [Abstract][Full Text] [Related]
4. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma. Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409 [TBL] [Abstract][Full Text] [Related]
5. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults. Ni CM; Greenstone IR; Ducharme FM Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751 [TBL] [Abstract][Full Text] [Related]
6. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over. Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271 [TBL] [Abstract][Full Text] [Related]
7. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years. Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272 [TBL] [Abstract][Full Text] [Related]
8. Inhaled corticosteroid therapy for patients with persistent asthma: learnings from studies of inhaled budesonide. Chipps BE Allergy Asthma Proc; 2009; 30(3):217-28. PubMed ID: 19344546 [TBL] [Abstract][Full Text] [Related]
9. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ram FS; Cates CJ; Ducharme FM Cochrane Database Syst Rev; 2005 Jan; (1):CD003137. PubMed ID: 15674901 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. Gibson PG; Powell H; Ducharme FM J Allergy Clin Immunol; 2007 Feb; 119(2):344-50. PubMed ID: 17291852 [TBL] [Abstract][Full Text] [Related]
11. Update on National Asthma Education and Prevention Program pediatric asthma treatment recommendations. Eid NS; Clin Pediatr (Phila); 2004; 43(9):793-802. PubMed ID: 15583774 [TBL] [Abstract][Full Text] [Related]
12. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007. National Asthma Education and Prevention Program J Allergy Clin Immunol; 2007 Nov; 120(5 Suppl):S94-138. PubMed ID: 17983880 [TBL] [Abstract][Full Text] [Related]
13. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM; Lasserson TJ; Cates CJ Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161 [TBL] [Abstract][Full Text] [Related]
14. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines. Prenner BM Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276 [TBL] [Abstract][Full Text] [Related]
15. Long-acting beta2-agonists or leukotriene receptor antagonists as add-on therapy to inhaled corticosteroids for the treatment of persistent asthma. Ringdal N Drugs; 2003; 63 Suppl 2():21-33. PubMed ID: 14984078 [TBL] [Abstract][Full Text] [Related]
16. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations. Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106 [TBL] [Abstract][Full Text] [Related]
17. Step-Down Therapy for Asthma Well Controlled on Inhaled Corticosteroid and Long-Acting Beta-Agonist: A Randomized Clinical Trial. Rogers L; Sugar EA; Blake K; Castro M; Dimango E; Hanania NA; Happel KI; Peters SP; Reibman J; Saams J; Teague WG; Wise RA; Holbrook JT; J Allergy Clin Immunol Pract; 2018; 6(2):633-643.e1. PubMed ID: 28974349 [TBL] [Abstract][Full Text] [Related]
18. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M; Greenstone IR; Danish A; Magdolinos H; Masse V; Zhang X; Ducharme FM Cochrane Database Syst Rev; 2005 Oct; (4):CD005535. PubMed ID: 16235410 [TBL] [Abstract][Full Text] [Related]
19. Application of multicategory exposure marginal structural models to investigate the association between long-acting beta-agonists and prescribing of oral corticosteroids for asthma exacerbations in the Clinical Practice Research Datalink. Ali AK; Hartzema AG; Winterstein AG; Segal R; Lu X; Hendeles L Value Health; 2015 Mar; 18(2):260-70. PubMed ID: 25773561 [TBL] [Abstract][Full Text] [Related]